http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03022302-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_914dc61e137493df775e2e2c6bc6f817
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db299197d01ed3e018d63d3f30cc1d80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27155ed29f9b0bfa281f4b21b26d709a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-06
filingDate 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d71ebb3a1e3e571741e248d936e22e
publicationDate 2003-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03022302-A2
titleOfInvention USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
abstract The invention provides a protocol leading to improved embryo implantation rates and/or decreased miscarriage rates in which hCG, or a bio-analogue, is administered during the follicular phase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2292252-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9676835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004069271-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004243256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9353172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013010840-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11185348-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526390-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2292252-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11292824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11091737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004105788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7985732-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3541418-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014159813-A1
priorityDate 2001-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9913081-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0067778-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0050066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5705478-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0154715-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1548953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25074470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134688829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534840
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399323

Total number of triples: 58.